The molecular platform making a difference towards personalised treatment.


Introducing breakthrough oligonucleotide therapies in viral and cancer diseases,

and modulating immune responses.

About Sepia

Sepia Molecular Holdings GmbH is developing oligonucleotide-based breakthrough molecular therapies in viral and cancer diseases, and modulating immune responses.

Virion Dome

The Virion Dome platform focuses on developing siRNA and DNA-based therapies for treating viral diseases such as Herpes (HSV-1+2), SARS (Covid-19) and others.

Cancer Dome

The Cancer Dome platform focuses on developing siRNA–based therapies to prevent metastatic development after primary surgery and treat local metastatic events.

Diagnostics Dome

Our diagnostics device is a simple, low-blood volume, bedside compatible workflow that allows high sensitivity and specificity in bacterial and virus-induced sepsis using molecular, macrophage-enhanced techniques.


Report abuse